Real-World Effectiveness, Drug Survival, and Safety of Risankizumab in Patients With Moderate to Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasis
J Eur Acad Dermatol Venereol 2024 Mar 20;[EPub Ahead of Print], N Rompoti, I Stefanaki, P Panagakis, M Papoutsaki, M Politou, C Vavouli, A Befon, F Kousta, E Lazou, M Zaimi, IA Koumprentziotis, V Chasapi, D Rigopoulos, A Stratigos, E NicolaidouFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.